Product Information
TRICOR 145 MG TABLET is a brand product labeled by AbbVie Inc., priced at $0.9997 per EA under NDC 00074318990. Its NADAC has been published 210 times since Sep 14, 2016.
The High Outlier badge above means this manufacturer's average price in the Fenofibrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
145 mg/1
Manufacturer
AbbVie Inc.NDC
00074318990
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
FENOFIBRATEApproval Type
New Drug (NDA)
FDA Application
NDA021656On Market Since
2/5/2016
Pharmacological Classes
Price Statistics
The NADAC for TRICOR 145 MG TABLET has been published 210 times since Sep 14, 2016, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9997 per EA |
|---|---|
| All-time high | $1.0120 (Jan 11, 2017) |
| All-time low | $0.9864 (Jan 18, 2017) |
| 52-week high | $0.9997 |
| 52-week low | $0.9997 |
| Median price | $0.9994 |
| Average price | $0.9965 |
| Largest weekly change | -2.5% (Jan 18, 2017) |
| Weeks tracked | 210 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRICOR 145 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRICOR 145 MG TABLET, manufactured by AbbVie Inc., is $0.9997 per EA (NDC 00074318990), effective Feb 11, 2026.
How has the price of TRICOR 145 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRICOR 145 MG TABLET has held within roughly two percent of its current level. It has been tracked across 210 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for TRICOR 145 MG TABLET?
Since Sep 14, 2016, the NADAC for TRICOR 145 MG TABLET has ranged from a low of $0.9864 (Jan 18, 2017) to a high of $1.0120 (Jan 11, 2017), with a median of $0.9994 per EA.
Are there cheaper alternatives to TRICOR 145 MG TABLET?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, FENOFIBRATE 145 MG TABLET, is $0.1198 per EA — about 88% below TRICOR 145 MG TABLET.
Who manufactures TRICOR 145 MG TABLET?
TRICOR 145 MG TABLET (NDC 00074318990) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification